Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population‐based study-Reference-Cited by-同舟云学术

Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population‐based study

Published:2019-03-24 Issue:1 Volume:186 Page:37-44
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Sverrisdóttir Ingigerður S.¹^ORCID,Lund Sigrún H.²,Turesson Ingemar³^ORCID,Björkholm Magnus⁴,Goldin Lynn R.⁵^ORCID,Landgren Ola⁶,Kristinsson Sigurður Y.²⁷

Affiliation:

1. Landspítali, National University Hospital Reykjavík Iceland

2. Faculty of Medicine University of Iceland ReykjavíkIceland

3. Skåne, University Hospital Malmö Malmö Sweden

4. Department of Medicine Division of Haematology Karolinska University Hospital and Karolinska Institutet Stockholm Sweden

5. Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda MDUSA

6. Myeloma Service Division of Hematology Oncology Department of Medicine Memorial Sloan‐Kettering Cancer Center New York NY USA

7. Department of Haematology Landspitali, National University Hospital Reykjavik Iceland

Funder

Karolinska Institutet

Icelandic Centre for Research

National Cancer Institute

Cancerfonden

Stockholms Läns Landsting

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15883

Reference47 articles.

1. The familial component in longevity—A study of offspring of nonagenarians: III. Intrafamilial studies

2. Familial longevity and prognosis in Hodgkin's disease

3. A Comparative Study of Monoclonal Gammopathies and Immunoglobulin Levels in Japanese and United States Elderly

4. Family patterns of coronary heart disease mortality: The Framingham Longevity Study